Search alternatives:
teer decrease » greater decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
Showing 701 - 720 results of 102,574 for search '(( 5 c decrease ) OR ( 5 ((((teer decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 701
    Decreased neutrophils in <i>MiR125a</i><sup><i>-/-</i></sup> mice.

    Decreased neutrophils in <i>MiR125a</i><sup><i>-/-</i></sup> mice. by Yuting Qin (1950118)

    Published 2017
    Save to List
    Saved in:
  2. 702
    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA.

    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 703
    Decrease of mitochondrial protein levels in human OPMD muscle biopsies.

    Decrease of mitochondrial protein levels in human OPMD muscle biopsies. by Aymeric Chartier (713911)

    Published 2015
    Save to List
    Saved in:
  4. 704
    Plasma CNAs levels decrease after anti-malarial chemotherapy.

    Plasma CNAs levels decrease after anti-malarial chemotherapy. by Bernardo S. Franklin (220946)

    Published 2011
    Save to List
    Saved in:
  5. 705
    Decrease of GFP-TbAtg8 fluorescence during starvation.

    Decrease of GFP-TbAtg8 fluorescence during starvation. by Remo S. Schmidt (546946)

    Published 2014
    Save to List
    Saved in:
  6. 706
    The decrease of C/EBPα protein during apoptosis involves induction of protein degradation and inhibition of transcription.

    The decrease of C/EBPα protein during apoptosis involves induction of protein degradation and inhibition of transcription. by Meng Zhao (54299)

    Published 2009
    “…Folds of decrease of C/EBPα protein/β-actin ratios against untreated cells are shown as means±SD of three independent experiments. …”
    Save to List
    Saved in:
  7. 707
    Decrease in GABA<sub>B</sub> expression in APP mice.

    Decrease in GABA<sub>B</sub> expression in APP mice. by Ksenia V. Kastanenka (3692380)

    Published 2017
    Save to List
    Saved in:
  8. 708
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 709
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 710
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 711
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 712
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 713
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 714
    Decreased expression of SMAD1/5/8 and VEFG in the Botox injected side MCC and subchondral bone.

    Decreased expression of SMAD1/5/8 and VEFG in the Botox injected side MCC and subchondral bone. by Eliane H. Dutra (3207312)

    Published 2016
    Save to List
    Saved in:
  15. 715
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 716
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 717
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 718
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 719
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 720
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: